Harvard Bioscience, Inc. (HBIO)
NASDAQ·Healthcare·Medical - Instruments & Supplies
$8.35
+0.36%
Mkt Cap $21.73M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
-28.1%
Consensus $6.00 vs current $8.35